BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23114702)

  • 1. Sublethal staphylococcal enterotoxin B challenge model in pigs to evaluate protection following immunization with a soybean-derived vaccine.
    Hudson LC; Seabolt BS; Odle J; Bost KL; Stahl CH; Piller KJ
    Clin Vaccine Immunol; 2013 Jan; 20(1):24-32. PubMed ID: 23114702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
    Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
    Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B.
    Hudson Reichenberg LC; Garg R; Fernalld R; Bost KL; Piller KJ
    Toxicon; 2017 Jul; 133():82-90. PubMed ID: 28478060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
    Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
    Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.
    Lee JS; Dyas BK; Nystrom SS; Lind CM; Smith JF; Ulrich RG
    J Infect Dis; 2002 Apr; 185(8):1192-6. PubMed ID: 11930333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soybean seeds: a practical host for the production of functional subunit vaccines.
    Hudson LC; Garg R; Bost KL; Piller KJ
    Biomed Res Int; 2014; 2014():340804. PubMed ID: 24822195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo.
    Baliban SM; Michael A; Shammassian B; Mudakha S; Khan AS; Cocklin S; Zentner I; Latimer BP; Bouillaut L; Hunter M; Marx P; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Infect Immun; 2014 Oct; 82(10):4080-91. PubMed ID: 25024365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
    Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
    Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
    Woody MA; Krakauer T; Stiles BG
    Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.
    Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Ulrich RG; Bavari S
    Vaccine; 2003 Jun; 21(21-22):2791-6. PubMed ID: 12798619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of recombinant Bacillus subtilis spores expressing mutant staphylococcal enterotoxin B provides potent protection against lethal enterotoxin challenge.
    Xiong Z; Mai J; Li F; Liang B; Yao S; Liang Z; Zhang C; Gao F; Ai X; Wang J; Long Y; Yang M; Gong S; Zhou Z
    AMB Express; 2020 Dec; 10(1):215. PubMed ID: 33315153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
    Mocca CP; Brady RA; Burns DL
    Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant HcpA-EspA-Tir-Stx2B chimeric protein induces immunity against attachment and toxicity of Escherichia coli O157:H7.
    Kordbacheh E; Nazarian S; Hajizadeh A; Fasihi-Ramandi M; Fathi J
    Microb Pathog; 2019 Apr; 129():176-182. PubMed ID: 30731187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.
    Lu T; Moxley RA; Zhang W
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
    Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Torres E; Dyas B; Ulrich RG; Bavari S
    Clin Immunol; 2003 Jul; 108(1):51-9. PubMed ID: 12865071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
    Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
    Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.